Two Sigma Investments
JSPR icon

Two Sigma Investments’s Jasper Therapeutics JSPR Stock Holding History

Two Sigma Investments’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40,427
Closed -$96.2K – 4244
2025
Q3 		$96.2K Buy
+40,427
New +$123K ﹤0.01% 3477
2024
Q1 		– Sell
-5,417
Closed -$42.7K – 3201
2023
Q4 		$42.7K Sell
5,417
-1,192
-18% -$8K ﹤0.01% 3008
2023
Q3 		$46.3K Buy
+6,609
New +$80.7K ﹤0.01% 2825
2023
Q2 		– Sell
-4,225
Closed -$76.5K – 3142
2023
Q1 		$76.5K Buy
+4,225
New +$78.1K ﹤0.01% 2706

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments's JSPR Position: Q4 2025 in Review

Two Sigma Investments sold out of Jasper Therapeutics (JSPR) in Q4 2025, closing a stake of 40,427 shares — an estimated $96.2K sold.

Two Sigma Investments first reported a position in JSPR in Q1 2023 and held it in 4 quarters. The position peaked at $96.2K in Q3 2025. 55 funds tracked by Wall St. Rank hold JSPR as of Q4 2025.

  • Two Sigma Investments reported no remaining Jasper Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Investments sold 40,427 Jasper Therapeutics shares in Q4 2025, an estimated $96.2K.
  • Two Sigma Investments first reported a position in Jasper Therapeutics in Q1 2023 and held it in 4 quarters.
  • Two Sigma Investments's Jasper Therapeutics position peaked at $96.2K in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q4 2025.

Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.